Tools · Private company · Rockville, MD, US
Sigmovir Biosystems, Inc.
Track this companyFree. Adds Sigmovir Biosystems, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Task A88: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related VirusesFiscal year 2025 · $282.7KNIH RePORTER 272201700028I-P00004-759302300001-1 · fetched Nov 12, 2026
- RXR/PPARg heterodimer agonists for treating virus-induced acute lung injuryFiscal year 2025 · $72.9KNIH RePORTER 5R03AI186104-02 · fetched Nov 12, 2026
- RXR/PPARg heterodimer agonists for treating virus-induced acute lung injuryFiscal year 2024 · $72.9KNIH RePORTER 1R03AI186104-01 · fetched Nov 12, 2026
- Task A88: Cotton Rat Model for the Evaluation of Vaccines and Therapeutics for RSV and Related VirusesFiscal year 2024 · $407.2KNIH RePORTER 272201700028I-P00002-759302300001-1 · fetched Nov 12, 2026
- Inducible HMGB1 antagonist for viral-induced acute lung injury.Fiscal year 2024 · $29.6KNIH RePORTER 3R41HL167254-01S1 · fetched Nov 12, 2026
- Inducible HMGB1 antagonist for viral-induced acute lung injury.Fiscal year 2024 · $62.9KNIH RePORTER 3R41HL167254-02S1 · fetched Nov 12, 2026
- Inducible HMGB1 antagonist for viral-induced acute lung injury.Fiscal year 2024 · $488.1KNIH RePORTER 5R41HL167254-02 · fetched Nov 12, 2026
- REAGENTS FOR IMMUNOLOGIC ANALYSIS OF COTTON RAT.Fiscal year 2024 · $598.9KNIH RePORTER 75N93024C00040-0-9999-1 · fetched Nov 12, 2026
- Pre-Clinical Models of Infectious DiseasesFiscal year 2024 · $2.5KNIH RePORTER 75N93024D00020-0-759302400001-1 · fetched Nov 12, 2026
- Task A07: Collection of Metadata from In Vivo Studies Performed Under Previous IDIQ Contract MechanismsFiscal year 2024 · $80.4KNIH RePORTER 75N93024D00020-0-759302400002-1 · fetched Nov 12, 2026